Comorbidity and Multimorbidity in Adults With Congenital Heart Disease: Findings From a Multi‐Site Population‐Based Study
Lorenzo D. Botto(Centers for Disease Control and Prevention), Jennifer S. Li(Duke University), Amber Khanna(Children's Hospital Colorado), Kevin J. Whitehead(University of Utah), Marcia L. Feldkamp(University of Utah), George K. Lui(Stanford Medicine), Aida Soim(New York State Department of Health), Fred H. Rodriguez(Emory University Hospital), Matthew R. Reeder(Cleveland Clinic), Karrie F. Downing(Centers for Disease Control and Prevention), Alfred D’Ottavio(Duke University), Sergey Krikov(University of Utah), Jesse DeLaRosa(Clinical Research Institute), Tessa Crume(Colorado School of Public Health), Nelangi M. Pinto(University of Utah), Jill Glidewell(Centers for Disease Control and Prevention), Daphne T. Hsu, Wendy M. Book(Emory University), Karen Chiswell(Amyloidosis Foundation)
Cited by 1
Related Papers
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Racial and Temporal Variations in the Prevalence of Heart Defects
|PEDIATRICS|2001|575
Mortality Associated With Congenital Heart Defects in the United States
|Circulation|2001|567
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies
|Birth Defects Research Part A Clinical and Molecular Teratology|2007|464